Prasad S. Adusumilli, MD, FACS

I conduct laboratory research focused on the development of biomarkers (blood tests) for early detection of cancer and gene therapy for thoracic cancers. These therapies include immunotherapy (enhancing patients’ own immune systems using genetic and cell engineering) and oncolytic viral therapy (killing cancer cells using genetically engineered viruses).

This research is supported by the National Cancer Institute, the Department of Defense, the American Association for Cancer Research, the International Association for the Study of Lung Cancer, the National Lung Cancer Partnership, the American Association for Thoracic Surgery, the Mesothelioma Applied Research Foundation, the Esophageal Cancer Education Foundation, the New York State Empire Clinical Research Investigator Program, the Stony Wold-Herbert Fund, and Memorial Sloan-Kettering’s Experimental Therapeutics Center, as well as several other foundations.

I mentor surgical trainees, research fellows, and bioengineering students (from the City College of New York). The strength of their training is reflected in their multiple presentations at international conferences and peer-reviewed publications.